Our results suggested a significant publication bias for the HLA-B*15–2 and its association with the risk of carbamazepine-induced serious cutaneous reactions and of phenytoin-induced SJS or TEN. This evidence concerns the gene HLA-B and toxic epidermal necrolysis.